Shengnan Bao
Shengnan Bao publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cancer Research, on topics such as Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research and Breast Cancer Treatment Studies.
- World rank
- #6,118,037 of 7,710,434 ranked researchers
- Rank in China
- #859,374 of 978,568
- Works
- 17
- Citations
- 125
- Citations per work
- 7.4
What does Shengnan Bao research?
Shengnan Bao's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1162.8%
- Medicine1162.8%
- Everything else319.6%
- Life Sciences317.6%
- 1Pulmonary and Respiratory Medicine28% of their works
- 2Oncology26% of their works
- 3Cancer Research10% of their works
- 4Molecular Biology8% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Epidemiology4% of their works
Research topics
Which keywords describe Shengnan Bao's research?
The keywords of their largest research topics: Breast Cancer, Metastatic Breast Cancer, CDK4/6 Inhibitors, Gene Expression, Palbociclib, HER2, Molecular Subtypes and Trastuzumab.
- Taxanes
- Multiple Primary Cancers
- Gynecomastia
- Chronic Lymphocytic Leukemia
- Ferroptosis
- Treatment Response
- Trastuzumab
- HER2
- Gene Expression
- Metastatic Breast Cancer
- Breast Cancer
- CDK4/6 Inhibitors
- Palbociclib
- Molecular Subtypes
- Breast Tumours
- Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- Genomic Aberrations
- Male Breast Cancer
- Second Primary Neoplasms
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Breast Cancer132 topics
- Metastatic Breast Cancer92 topics
- CDK4/6 Inhibitors71 topic
- Gene Expression72 topics
- Palbociclib71 topic
- HER261 topic
- Molecular Subtypes62 topics
- Trastuzumab61 topic
- Breast Tumours41 topic
- Treatment Response41 topic
- Cancer31 topic
- Ferroptosis31 topic
- Chemotherapy-Induced Peripheral Neuropathy21 topic
- Chronic Lymphocytic Leukemia21 topic
- Genomic Aberrations21 topic
- Gynecomastia21 topic
- Male Breast Cancer21 topic
- Multiple Primary Cancers21 topic
- Second Primary Neoplasms21 topic
- Taxanes21 topic
Where does Shengnan Bao work?
Shengnan Bao's main affiliation in the publication record is Nanjing Medical University, China.
How many publications and citations does Shengnan Bao have?
OpenAlex counts 17 works and 125 citations for Shengnan Bao, an h-index of 7, ranking #6,118,037 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shengnan Bao. Posts are plain text and can be reported.